USP: Second Stimuli Article on Instrument Qualification published for Comments
Recommendation
17/18 September 2024
With updates on the CEP 2.0!
As of early March 2022, the stimuli document "Measurement Uncertainty Evaluation Relevant to Analytical Instrument and System (AIS) Qualification - The Role of Measurement Uncertainty Concepts within the AIS - PF 48(2)" has been posted on the USP Pharmacopeial Forum website for comment. Comments and remarks on this draft can be submitted until 31 May 2022.
This draft is divided into the following chapters:
- Introduction
- AIS Uncertainty Contributions to the Analytical Procedure
- Evaluation of Measurement Uncertainty with Focus on UAIS
- Example - HPLC-UV Assay Method
- Conclusion
- References
The Stimuli document can be checked and commented on after a one-time registration on the Pharmacopeial Forum website.
Here you can also review the Stimuli article on "Analytical Instrument and System (AIS) Qualification, to support Analytical Procedure Validation over the Life Cycle- PF 48(1)" and comment on it until 31 March 2022 - as recently reported.
Related GMP News
21.08.2024FDA issues Warning to Jordanian OTC Manufacturer
14.08.2024FDA Issues Warning Letter to Vietnamese Drug Manufacturer for CGMP Violations
24.07.2024FDA Warning Letter to Chinese OTC Manufacturer for Lack of Analytical Test Data
10.07.2024Pharmeuropa: Two Revised Chapters on Dissolution Testing published for comments
03.07.2024FDA Warning Letter: GMP Requirements also apply to HPLC Analyses for Internal Use
12.06.2024NMPA Announcement on Application of ICH Q2(R2) and Q14 Principles